C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
12/2001
12/11/2001	US6329395 Urea derivatives for treating an eating disorder or diabetes comprising administering an effective amount of a compound of claim 1 to a mammal
12/11/2001	US6329378 Heterocyclic fungicides and antigrowth agents
12/11/2001	US6329374 Non-systemic control of parasites
12/11/2001	US6329373 Metalloproteinase inhibitors
12/11/2001	US6329372 Phenylalanine derivatives
12/11/2001	US6329371 α-substrates benzyl heterocyclic derivatives, intermediates for producing the same and agrochemical composition containing the same as active ingredient
12/11/2001	US6329362 Modulation cell adhesion the compounds are able to inhibit the binding of alpha 4 integrins to their ligands and are of use in the prophylaxis and treatment of immune or inflammatory disorders.
12/11/2001	US6329360 Hetero-linked phenylglycinolamides
12/11/2001	CA2205033C Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas as 5-lipoxygenase inhibitors
12/11/2001	CA1341325C Triazole antifungal agents
12/08/2001	CA2348373A1 Improved process for preparing substituted pyridines
12/06/2001	WO2001092277A1 Metallocenes as signal-transducer for detection of chemical or biological events
12/06/2001	WO2001092241A1 Benzamide derivatives and their use as apob-100 and mtp inhibitors
12/06/2001	WO2001092230A1 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- [2,3']bipyridinyl in pure crystalline form and process for synthesis
12/06/2001	WO2001092229A1 TNF-α PRODUCTION INHIBITORS
12/06/2001	WO2001092218A2 Polyamine analogues as therapeutic and diagnostic agents
12/06/2001	WO2001092212A1 Excitatory amino acid receptor modulators
12/06/2001	WO2001092211A1 Compounds exhibiting thrombopoietin-like activities
12/06/2001	WO2001092202A1 Il-8 receptor antagonists
12/06/2001	WO2001092188A1 Method for labeling with tritium
12/06/2001	WO2001017999A3 Amino-triazolopyridine derivatives
12/06/2001	WO2001010847A8 Novel integrin receptor antagonists
12/06/2001	US20010049444 Pyridine-substituted benzanilides as potassium ion channel openers
12/06/2001	US20010049379 Nitric oxide synthase inhibitors; treatment and prevention of central nervous system and other disorders.
12/06/2001	US20010049374 Amidino derivatives of quinoline and naphthalene
12/06/2001	US20010049367 Cyclic and bicyclic diamino histamine-3 receptor antagonists
12/06/2001	DE10027025A1 Clycinamide Clycinamide
12/06/2001	DE10027024A1 Carbaminsäureester Carbamic
12/06/2001	DE10026565A1 Ionische Flüssigkeiten Ionic Liquids
12/06/2001	CA2736344A1 Tnf-.alpha. production inhibitors
12/06/2001	CA2411323A1 Il-8 receptor antagonists
12/06/2001	CA2410935A1 Novel polyamine analogues as therapeutic and diagnostic agents
12/06/2001	CA2410240A1 Metallocenes as signal-transducer for detection of chemical or biological events
12/05/2001	EP1160249A2 Ionic liquids
12/05/2001	EP1160242A1 Aromatic fatty acid esters
12/05/2001	EP1160240A1 Guanylhydrazones for treating inflammatory conditions
12/05/2001	EP1159270A2 1-(6- methylpyridine- 3-yl)-2- 4- (methylsulfonyl) phenyl] ethanone and method for its preparation
12/05/2001	EP1159264A2 INHIBITORS OF FACTOR Xa
12/05/2001	EP1159261A2 Antizyme modulators and their use
12/05/2001	EP1159258A1 Amide compounds for the potentiation of cholinergic activity
12/05/2001	EP1158985A1 OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
12/05/2001	EP0991793B1 Method for preparing 2-aryl or 2-heterocyclyl chiral propionic acids and their esters
12/05/2001	EP0911327B1 Novel pyridonecarboxylic acid derivatives or their salts and antibacterial agent comprising the same as the active ingredient
12/05/2001	EP0835244B1 Diheterocyclic acrylonitriles as smooth muscle cell proliferation inhibitors
12/05/2001	EP0754176B1 Novel carbamates and ureas as modifiers of multi-drug resistance
12/05/2001	EP0636026B1 Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor
12/05/2001	CN1325470A Method of treating a textile
12/05/2001	CN1325435A Bleaching composition and method for bleaching a sustrate
12/05/2001	CN1325431A Electrolumiscent materials
12/05/2001	CN1325384A Anthranilic acid amides and the use thereof as medicaments
12/05/2001	CN1325380A Benzene derivatives and medical use thereof
12/05/2001	CN1325376A Novel compounds and medicinal use thereof
12/05/2001	CN1325308A Use of neurotrophic factor stimulators for treatment of ophthalmic neurodegenerative diseases
12/05/2001	CN1075817C Hydro philic metal complexes
12/05/2001	CN1075807C Iminooxymethylene anilides, process and intermediate products for preparing the same and pesticides containing the same
12/04/2001	USH2007 Insecticidal N-heterocyclylalkyl-or N-[(polycyclyl)alkyl]-N′substituted piperazines
12/04/2001	US6326512 Hydrogenation a b-ketosulfonic acid compound
12/04/2001	US6326386 Anticoagulant
12/04/2001	US6326385 Administering poltassium channel modulator
12/04/2001	US6326375 Containing an urea group
12/04/2001	US6326371 Pyrudyl and pyrimidylpiperazine derivatives
12/04/2001	US6326369 Bicyclic quinone compounds, their production and use
12/04/2001	US6326066 1,4-disubstituted 2,6-difluorobenzene compounds, and a liquid-crystalline medium
11/2001
11/30/2001	CA2348966A1 Ionic liquids
11/29/2001	WO2001090251A1 Antimicrobial composition
11/29/2001	WO2001090076A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
11/29/2001	WO2001090074A2 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a)
11/29/2001	WO2001090073A1 New process
11/29/2001	WO2001090072A1 Novel synthesis of heteroarylamine intermediate compounds
11/29/2001	WO2001090071A2 Substituted iminoazines used as herbicides
11/29/2001	WO2001089457A2 Thrombopoietin mimetics
11/29/2001	WO2001070695A8 Pyridine derivatives as inhibitors of p38
11/29/2001	WO2001055115A8 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/29/2001	WO2000040210A3 Topical compositions comprising protected functional thiols
11/29/2001	US20010047099 4-aminopicolinates and their use as herbicides
11/29/2001	US20010047006 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
11/29/2001	EP1143916A3 Topical compositions comprising protected functional thiols
11/29/2001	DE10025728A1 Neue Carbamate und Harnstoffe, ihre Herstellung und Verwendung als Endothelin-Rezeptorantagonisten New carbamates and ureas, their preparation and use as endothelin receptor antagonists
11/29/2001	CA2409667A1 New process
11/29/2001	CA2409142A1 Substituted iminoazines
11/29/2001	CA2408727A1 Benzophenones as inhibitors of il-1.beta. and tnf-.alpha.
11/29/2001	CA2407780A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
11/28/2001	EP1158358A2 Imaging element containing a blocked photographically useful compound
11/28/2001	EP1158037A1 Fluoro-substitued alkenyl compounds, liquid crystal compositions, and liquid crystal display elements
11/28/2001	EP1157022A1 Pyridine compounds and their pharmaceutical use
11/28/2001	EP1157007A1 Pde iv inhibiting compounds, compositions and methods of treatment
11/28/2001	EP1157006A2 Phenyl- and pyridinyl derivatives as neurokinin 1 antagonists
11/28/2001	EP1157005A1 3-phenylpyridine derivatives and their use as nk-1 receptor antagonists
11/28/2001	EP1157003A1 Acylated aminoacetonitriles as cysteine protease inhibitors
11/28/2001	EP1157002A1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy
11/28/2001	EP0944690B1 1,1,5,7-tetrafluoro-1,2,3,4-tetrahydronaphthalene derivatives and their use in liquid crystal mixtures
11/28/2001	EP0673368B1 Novel nicotinic acid esters
11/28/2001	CN1324347A Arylpiperzines as metalloproteinase inhibiting agents (MMP) and their use
11/28/2001	CN1324344A N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
11/28/2001	CN1075490C O-benzyl oxime ether derivatives and their use in crop production compositions
11/27/2001	US6323366 Arylamine synthesis
11/27/2001	US6323229 Compounds are useful psychotherapeutics and are potent agonists and/or antagonists of the serotonin 1a (5-ht 1a) and/or serotonin 1d (5-ht 1d) for treatment of hypertension, depression, generalized anxiety disorder
11/27/2001	US6323227 Prodrugs
11/27/2001	US6323223 Ccr-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use and methods for preparing these compounds.
11/27/2001	US6323220 Substituted pyridine or piperidine compounds

1 ... 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 ... 633